Stock & Company Details
Anteris Technologies Global Corp. $AVR
Price:
N/A
N/A
97M
$646M
52 Week High:
N/A
10 Day Average Volume:
N/A
-3.00
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
N/A
AVR technical indicators
Latest Anteris Technologies Global Corp. (AVR) indicator readings as of 2026-10-09.
AVR's 14-day RSI is 29.0, in oversold territory. At $6.77 it is trading 7.2% below its 200-day moving average of $7.30, and below its 50-day average of $8.36. Price sits near the lower Bollinger Band ($6.60 to $8.84). ADX reads 19.0, indicating a range-bound market rather than a trend.
Overview
Anteris Technologies Global Corp is a structural heart company committed to discovering, developing and commercializing innovative medical devices designed to improve the quality of life for patients with aortic stenosis. Its lead product, the DurAVR THV system, represents a unique product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Its DurAVR THV system consists of a single-piece, biomimetic valve made with its proprietary ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold.
Finance Bot
Ask your questions
Start by typing a question below.
